Literature DB >> 24357309

Cell Biology. Ronning after the adiponectin receptors.

William L Holland1, Philipp E Scherer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24357309      PMCID： PMC4084614          DOI： 10.1126/science.1249077

Source DB:  PubMed          Journal:  Science        ISSN： 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  15 in total

1.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.

Authors:  A H Berg; T P Combs; X Du; M Brownlee; P E Scherer
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

2.  Optimization of protein production in mammalian cells with a coexpressed fluorescent marker.

Authors:  Filippo Mancia; Saurabh D Patel; Michael W Rajala; Philipp E Scherer; Adriana Nemes; Ira Schieren; Wayne A Hendrickson; Lawrence Shapiro
Journal:  Structure       Date:  2004-08       Impact factor: 5.006

3.  A novel serum protein similar to C1q, produced exclusively in adipocytes.

Authors:  P E Scherer; S Williams; M Fogliano; G Baldini; H F Lodish
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

Review 4.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

5.  A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity.

Authors:  Terry P Combs; Utpal B Pajvani; Anders H Berg; Ying Lin; Linda A Jelicks; Mathieu Laplante; Andrea R Nawrocki; Michael W Rajala; Albert F Parlow; Laurelle Cheeseboro; Yang-Yang Ding; Robert G Russell; Dirk Lindemann; Adam Hartley; Glynn R C Baker; Silvana Obici; Yves Deshaies; Marian Ludgate; Luciano Rossetti; Philipp E Scherer
Journal:  Endocrinology       Date:  2003-10-23       Impact factor: 4.736

6.  Adiponectin is a negative regulator of bone mineral and bone strength in growing mice.

Authors:  Kafi N Ealey; Jovana Kaludjerovic; Michael C Archer; Wendy E Ward
Journal:  Exp Biol Med (Maywood)       Date:  2008-10-10

7.  An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice.

Authors:  William L Holland; Andrew C Adams; Joseph T Brozinick; Hai H Bui; Yukiko Miyauchi; Christine M Kusminski; Steven M Bauer; Mark Wade; Esha Singhal; Christine C Cheng; Katherine Volk; Ming-Shang Kuo; Ruth Gordillo; Alexei Kharitonenkov; Philipp E Scherer
Journal:  Cell Metab       Date:  2013-05-07       Impact factor: 27.287

8.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

9.  Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin.

Authors:  William L Holland; Russell A Miller; Zhao V Wang; Kai Sun; Brian M Barth; Hai H Bui; Kathryn E Davis; Benjamin T Bikman; Nils Halberg; Joseph M Rutkowski; Mark R Wade; Vincent M Tenorio; Ming-Shang Kuo; Joseph T Brozinick; Bei B Zhang; Morris J Birnbaum; Scott A Summers; Philipp E Scherer
Journal:  Nat Med       Date:  2010-12-26       Impact factor: 53.440

10.  Cloning of adiponectin receptors that mediate antidiabetic metabolic effects.

Authors:  Toshimasa Yamauchi; Junji Kamon; Yusuke Ito; Atsushi Tsuchida; Takehiko Yokomizo; Shunbun Kita; Takuya Sugiyama; Makoto Miyagishi; Kazuo Hara; Masaki Tsunoda; Koji Murakami; Toshiaki Ohteki; Shoko Uchida; Sato Takekawa; Hironori Waki; Nelson H Tsuno; Yoichi Shibata; Yasuo Terauchi; Philippe Froguel; Kazuyuki Tobe; Shigeo Koyasu; Kazunari Taira; Toshio Kitamura; Takao Shimizu; Ryozo Nagai; Takashi Kadowaki
Journal:  Nature       Date:  2003-06-12       Impact factor: 49.962
View more
  33 in total

1.  AdipoRon, the first orally active adiponectin receptor activator, attenuates postischemic myocardial apoptosis through both AMPK-mediated and AMPK-independent signalings.

Authors:  Yanqing Zhang; Jianli Zhao; Rui Li; Wayne Bond Lau; Yue-Xing Yuan; Bin Liang; Rong Li; Er-He Gao; Walter J Koch; Xin-Liang Ma; Ya-Jing Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2015-06-02       Impact factor: 4.310

Review 2.  Adiponectin as a Potential Therapeutic Target for Prostate Cancer.

Authors:  Hanuma Kumar Karnati; Manas Kumar Panigrahi; Yazhou Li; David Tweedie; Nigel H Greig
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 3.  Insulin resistance in clinical and experimental alcoholic liver disease.

Authors:  Rotonya M Carr; Jason Correnti
Journal:  Ann N Y Acad Sci       Date:  2015-05-21       Impact factor: 5.691

4.  Adiponectin and its Hydrolase-Activated Receptors.

Authors:  Ankit X Sharma; William L Holland
Journal:  J Nat Sci       Date:  2017-06

5.  Oxidative Amide Coupling from Functionally Diverse Alcohols and Amines Using Aerobic Copper/Nitroxyl Catalysis.

Authors:  Paige E Piszel; Aristidis Vasilopoulos; Shannon S Stahl
Journal:  Angew Chem Int Ed Engl       Date:  2019-07-24       Impact factor: 15.336

6.  Tumor expression of adiponectin receptor 2 and lethal prostate cancer.

Authors:  Jennifer R Rider; Michelangelo Fiorentino; Rachel Kelly; Travis Gerke; Kristina Jordahl; Jennifer A Sinnott; Edward L Giovannucci; Massimo Loda; Lorelei A Mucci; Stephen Finn
Journal:  Carcinogenesis       Date:  2015-04-11       Impact factor: 4.944

7.  AdipoRon, an adiponectin receptor agonist, attenuates PDGF-induced VSMC proliferation through inhibition of mTOR signaling independent of AMPK: Implications toward suppression of neointimal hyperplasia.

Authors:  Arwa Fairaq; Noha M Shawky; Islam Osman; Prahalathan Pichavaram; Lakshman Segar
Journal:  Pharmacol Res       Date:  2017-02-22       Impact factor: 7.658

8.  The Adiponectin Receptor Agonist AdipoRon Ameliorates Diabetic Nephropathy in a Model of Type 2 Diabetes.

Authors:  Yaeni Kim; Ji Hee Lim; Min Young Kim; Eun Nim Kim; Hye Eun Yoon; Seok Joon Shin; Bum Soon Choi; Yong-Soo Kim; Yoon Sik Chang; Cheol Whee Park
Journal:  J Am Soc Nephrol       Date:  2018-01-12       Impact factor: 10.121

9.  AdipoRon, an adiponectin receptor agonist, attenuates cardiac remodeling induced by pressure overload.

Authors:  Ning Zhang; Wen-Ying Wei; Hai-Han Liao; Zheng Yang; Can Hu; Sha-Sha Wang; Wei Deng; Qi-Zhu Tang
Journal:  J Mol Med (Berl)       Date:  2018-10-19       Impact factor: 4.599

10.  AdipoRon Attenuates Inflammation and Impairment of Cardiac Function Associated With Cardiopulmonary Bypass-Induced Systemic Inflammatory Response Syndrome.

Authors:  Alexander Jenke; Mariam Yazdanyar; Shunsuke Miyahara; Agunda Chekhoeva; Moritz Benjamin Immohr; Julia Kistner; Udo Boeken; Artur Lichtenberg; Payam Akhyari
Journal:  J Am Heart Assoc       Date:  2021-03-05       Impact factor: 5.501
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.